SEC's recommends Corbevax COVID-19 vaccines for kids aged 5-11
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...
DCGI to discuss to use COVID-19 vaccines for 5-12 age group
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller...
DCGI claims India on course to become global drugs hub
Glenmark Specialty S.A. receives approval for conducting trial
Zydus Lifesciences gets DCGI approval for Oxemia drug
DCGI approves Themis Medicare's VIRALEX for Covid-19 treatment
New Delhi [India], March 5 (ANI/Target Media): In a landmark development for the treatment of COVID-19, Themis...
Bharat Biotech gets SEC approval for phase 3 clinical trials...
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India...
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Dr Dangs Lab as central lab conducted tests in all three...
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19...
Biological E gets approval to conduct trials of Corbevax as...
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the...
DCGI grants Cipla emergency use authorisation for COVID-19...
Zydus seeks DCGI nod for 'Desidustat' oral pill to treat...
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it...
Copyright © aninews.in | All Rights Reserved.